Navigation Links
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
Date:5/29/2009

regarding our intellectual property rights and those of others; difficulties associated with, and regulatory compliance with respect to, manufacturing of our products; risks associated with our strategic relationships; global economic conditions; interest and currency exchange rate fluctuations and volatility in the credit and financial markets; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission on February 27, 2009. The forward-looking statements in this press release are qualified by these risk factors. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
2. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
3. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
4. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
5. Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
6. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
7. Neuronetrix Announces Preliminary Alzheimers Study Results at the Society for Neuroscience Conference
8. CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
9. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa
10. What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study
11. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- Research and Markets has announced ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study ... devices. The report provides a basic ... and industry chain structure. The laparoscopic devices market ...
(Date:9/16/2014)... 16, 2014   Vestagen Technical Textiles, Inc. ... at hospitals. The myComfort™ line of patient apparel is ... that is fluid repellant, breathable and in studies done ... of bacteria on the fabric i . ... the chain of transmission. We want myComfort to be ...
(Date:9/16/2014)... BRIDGEWATER, N.J. , Sept. 16, 2014 /PRNewswire/ ... pharmaceutical company focused on developing and commercializing therapeutic ... renal and infectious diseases, announces the amendment and ... and E preferred stock and related warrants, as ... 2014 common stock and warrant financing, to remove ...
Breaking Medicine Technology:Global Laparoscopy Devices Industry Report 2014 2New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
... Pa., Feb. 16, 2011 AirPal, a medical device ... of allowance from the U.S. Patent Office for its ... for situations such as difficult airway management, laryngoscopies, diagnostic ... founded in 1982, now holds more than a dozen ...
... YORK, Feb. 16, 2011 Get content from ... The European Parliament is expected ... prevent falsified medicines from entering the legal distribution ... packages have reached patients in the last years. ...
Cached Medicine Technology:AirPal Receives Patent for Inflatable Patient Positioning Systems 2
(Date:9/16/2014)... Dog Food Secrets , a guide compiled ... ingredients in most commercial dog food but presents a better ... of Shane Michaels, prompting an investigative review. , “For ... family member as any other human is, which is why ... should due to poor diet” reports Michaels. “Most dog owners ...
(Date:9/16/2014)... (PRWEB) September 17, 2014 Operation Smile was ... die because of a facial deformity.” To spread their message ... September 19, 2014, at the Beverly Wilshire Hotel in Beverly ... young people worldwide whose lives have been forever transformed by ... to be involved with Operation Smile,” said Lynda Erkiletian, Executive ...
(Date:9/16/2014)... In a healthcare climate where the costs ... a Yale study has found that radiation oncologists ... elderly women with early-stage breast cancer. The findings ... annual conference of the American Society for Radiation ... Practice in Radiotherapy for Elderly Women: Response to ...
(Date:9/16/2014)... (PRWEB) September 17, 2014 ... hosting suppliers from the USA and announces ... ) are the best Windows web hosting ... on offering worldwide clients high quality WordPress ... low rates. , HostMonster provides outstanding ...
(Date:9/16/2014)... Not all recovery plans are alike, and ... sure all their patients are receiving the treatment that ... the newly-introduced online therapy. Millennium Treatment Group recently launched ... opportunity to seek treatment from home. , With online ... care at a distance. They provide patients with all ...
Breaking Medicine News(10 mins):Health News:Dog Food Secrets: Review Exposes Andrew Lewis’ Guide to Happier, Healthier Dogs with Homemade Dog Food 2Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2Health News:Best Windows Web Hosting Suppliers Recommended By SEO Hosting Review Site Top10BestSEOHosting.com 2Health News:Millennium Treatment Group Now Offers Online Therapy 2
... C with the standard therapy of pegylated-interferon and ribavirin would ... of Hepatology, a journal published by John Wiley ... Study of Liver Diseases (AASLD). The article is also available ... prisons incarcerate more than 2 million inmates each year, and ...
... to Be Served Beginning in ... ... been awarded the five-year Active Duty Dental Program (ADDP),contract by the United ... be awarded to the Harrisburg, PA-based,national dental insurer. The contract, which is ...
... Some Payers Scaling Back Chronic Disease,Initiatives, WASHINGTON, ... to reports that many Americans are forgoing basic,medical ... renewed vigilance,in the fight against chronic disease and ... of belt-tightening make sense in tough economic times,--dining ...
... & Grossman, LLC,announces that a class action lawsuit has ... District of Colorado against The Spectranetics,Corporation. ("Spectranetics" or the ... of purchasers of Spectranetics who purchased common,stock between April ... According to the complaint, the true facts, which ...
... channel count 12-bit ADC with Samplify,s, Prism(TM) data ... in ... SANTA CLARA, Calif., Oct. 20 Samplify ... family of true,16-channel, 12-bit, 65 Msample/sec analog-to-digital converter ...
... 20 Concentric Medical,Inc., the global leader in ... announced the launch of the Merci(R) Distal Access,Catheter, ... and enhanced support during minimally invasive procedures in ... using the Merci Retrieval System(TM),to remove thrombus in ...
Cached Medicine News:Health News:Hepatitis C treatment is cost-effective for the US prison population 2Health News:National Dental Insurer United Concordia to Receive $660 Million Contract From U.S. Department of Defense 2Health News:Nation's Economic Downturn Threatens Continuity of Care for Chronic Conditions 2Health News:Bronstein, Gewirtz & Grossman, LLC Announces that a Class Action has been Filed Against The Spectranetics Corporation 2Health News:Samplify Systems Announces Availability of World's First 16-channel, 12-bit, 65 Msps A/D Converter With Integrated Real-Time Data Compression 2Health News:Samplify Systems Announces Availability of World's First 16-channel, 12-bit, 65 Msps A/D Converter With Integrated Real-Time Data Compression 3Health News:Samplify Systems Announces Availability of World's First 16-channel, 12-bit, 65 Msps A/D Converter With Integrated Real-Time Data Compression 4Health News:Samplify Systems Announces Availability of World's First 16-channel, 12-bit, 65 Msps A/D Converter With Integrated Real-Time Data Compression 5
Agarose IEF is suitable for isoelectric focusing of large molecules and is the gel of choice for many IEF applications and immunochemical detection methods....
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
... White solid. Highly purified non-ionic fraction of ... at very low concentrations. Can be mounted ... dried, films are elastic and durable and ... with either protein or lipoprotein dyes. ...
Medicine Products: